Izea Worldwide (IZEA) Competitors $3.71 -0.02 (-0.54%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$3.70 -0.01 (-0.27%) As of 08/1/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock IZEA vs. OPRX, OABI, MXCT, PMTS, TCX, PESI, III, RGP, RCMT, and MIMIShould you be buying Izea Worldwide stock or one of its competitors? The main competitors of Izea Worldwide include OptimizeRx (OPRX), OmniAb (OABI), MaxCyte (MXCT), CPI Card Group (PMTS), Tucows (TCX), Perma-Fix Environmental Services (PESI), Information Services Group (III), Resources Connection (RGP), RCM Technologies (RCMT), and Mint Incorporation (MIMI). These companies are all part of the "business services" industry. Izea Worldwide vs. Its Competitors OptimizeRx OmniAb MaxCyte CPI Card Group Tucows Perma-Fix Environmental Services Information Services Group Resources Connection RCM Technologies Mint Incorporation Izea Worldwide (NASDAQ:IZEA) and OptimizeRx (NASDAQ:OPRX) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, analyst recommendations, profitability, dividends, institutional ownership and risk. Which has better valuation and earnings, IZEA or OPRX? OptimizeRx has higher revenue and earnings than Izea Worldwide. OptimizeRx is trading at a lower price-to-earnings ratio than Izea Worldwide, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIzea Worldwide$35.88M1.75-$18.85M-$0.93-3.99OptimizeRx$92.13M2.51-$18.66M-$0.84-14.88 Which has more volatility & risk, IZEA or OPRX? Izea Worldwide has a beta of 1.14, suggesting that its stock price is 14% more volatile than the S&P 500. Comparatively, OptimizeRx has a beta of 1.33, suggesting that its stock price is 33% more volatile than the S&P 500. Do analysts recommend IZEA or OPRX? OptimizeRx has a consensus price target of $10.81, suggesting a potential downside of 13.50%. Given OptimizeRx's stronger consensus rating and higher probable upside, analysts plainly believe OptimizeRx is more favorable than Izea Worldwide.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Izea Worldwide 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00OptimizeRx 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.73 Is IZEA or OPRX more profitable? OptimizeRx has a net margin of -16.33% compared to Izea Worldwide's net margin of -42.63%. OptimizeRx's return on equity of -0.29% beat Izea Worldwide's return on equity.Company Net Margins Return on Equity Return on Assets Izea Worldwide-42.63% -25.25% -20.32% OptimizeRx -16.33%-0.29%-0.20% Does the media favor IZEA or OPRX? In the previous week, OptimizeRx had 3 more articles in the media than Izea Worldwide. MarketBeat recorded 4 mentions for OptimizeRx and 1 mentions for Izea Worldwide. OptimizeRx's average media sentiment score of 0.80 beat Izea Worldwide's score of 0.66 indicating that OptimizeRx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Izea Worldwide 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OptimizeRx 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals hold more shares of IZEA or OPRX? 15.6% of Izea Worldwide shares are held by institutional investors. Comparatively, 76.5% of OptimizeRx shares are held by institutional investors. 4.9% of Izea Worldwide shares are held by insiders. Comparatively, 5.6% of OptimizeRx shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryOptimizeRx beats Izea Worldwide on 15 of the 16 factors compared between the two stocks. Get Izea Worldwide News Delivered to You Automatically Sign up to receive the latest news and ratings for IZEA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IZEA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IZEA vs. The Competition Export to ExcelMetricIzea WorldwideINTERNET SOFTWARE IndustryComputer SectorNASDAQ ExchangeMarket Cap$63.13M$19.21B$29.21B$9.53BDividend YieldN/A2.95%3.09%4.08%P/E Ratio-3.9985.9248.0923.80Price / Sales1.75154.431,545.0088.08Price / CashN/A92.4138.0757.96Price / Book1.298.087.415.55Net Income-$18.85M$341.62M$782.10M$259.03M7 Day Performance-5.84%-6.55%-3.63%-4.56%1 Month Performance44.92%0.45%-0.09%4.49%1 Year Performance76.67%56.29%52,642.36%18.05% Izea Worldwide Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IZEAIzea Worldwide0.9669 of 5 stars$3.71-0.5%N/A+69.4%$63.13M$35.88M-3.99130Analyst UpgradeOPRXOptimizeRx1.7748 of 5 stars$13.80-3.8%$10.81-21.6%+19.2%$265.40M$92.13M-16.43100News CoveragePositive NewsUpcoming EarningsOABIOmniAb3.079 of 5 stars$2.06-1.9%$7.00+239.8%-57.4%$256.48M$26.39M-3.557News CoveragePositive NewsUpcoming EarningsMXCTMaxCyte2.423 of 5 stars$2.26+0.4%$7.00+209.7%-55.4%$239.44M$38.63M-5.6580Upcoming EarningsPMTSCPI Card Group3.663 of 5 stars$20.98-0.1%$36.75+75.2%-34.0%$236.91M$480.60M13.191,500Upcoming EarningsTCXTucows0.5596 of 5 stars$19.96-3.2%N/A-30.4%$227.89M$362.27M-2.171,000Upcoming EarningsGap DownPESIPerma-Fix Environmental Services0.1165 of 5 stars$12.33flatN/A-12.2%$227.52M$59.12M-9.86290Positive NewsUpcoming EarningsIIIInformation Services Group3.901 of 5 stars$4.55+0.4%$5.50+20.9%+26.9%$218.37M$247.59M30.331,323Upcoming EarningsRGPResources Connection1.0397 of 5 stars$5.19-10.4%$5.00-3.7%-57.2%$191.47M$551.33M-0.893,376Analyst RevisionRCMTRCM Technologies2.4766 of 5 stars$25.57-1.1%$33.50+31.0%+21.8%$191.38M$278.38M14.783,140News CoverageUpcoming EarningsMIMIMint IncorporationN/A$8.74+10.2%N/AN/A$180.41MN/A0.0015News CoveragePositive News Related Companies and Tools Related Companies OptimizeRx Competitors OmniAb Competitors MaxCyte Competitors CPI Card Group Competitors Tucows Competitors Perma-Fix Environmental Services Competitors Information Services Group Competitors Resources Connection Competitors RCM Technologies Competitors Mint Incorporation Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IZEA) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Izea Worldwide, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Izea Worldwide With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
